Management of the SARS-CoV-2 pandemic (COVID-19) by the Moroccan National Blood Center: Reactivity, Adaptability and Governance - Abstract
At the end of 2019, a new coronavirus (SARS-CoV-2) was identified in people living in the city of Wuhan in China. The first people identified as infected went to the city’s seafood market, where live animals were also sold. Since the appearance of the first cases in Wuhan, the epidemic has spread to the international scale with actually at 18 May 4.679.511 cases and 315.005 deaths worldwide. The pandemic is considered by international scientific societies to have an impact on blood donation and transfusion activities at the level of transfusion establishments on an international scale. Efforts must, therefore, be made at the level of the transfusion centers to ensure proper management of this health
crisis at SARS-CoV-2.
The National Blood Center of Morocco has demonstrated a great reactivity and a great adaptability since the beginning of the epidemic according to the evolution of scientific data to ensure the availability and safety of blood products to patients.